Medicare Finalizes Modifier 25 Payment Cuts for 2027: What Podiatry Practices Need to Know

November 5, 2026 | Vital Profits LLC

Podiatrists frequently evaluate patients and perform medically necessary procedures during the same appointment. It's efficient, convenient for patients, and an important part of providing comprehensive foot and ankle care.

However, a newly finalized Medicare payment policy could reduce reimbursement for certain same-day services beginning January 1, 2027.

On November 4, 2026, the Centers for Medicare & Medicaid Services (CMS) released its final 2027 Medicare Physician Fee Schedule, confirming a 20% payment reduction affecting certain services reported with Modifier 25.

How Will the New Payment Reduction Work?

When a separately identifiable office or outpatient E/M visit is performed on the same day as a procedure with a 0-day global period, Medicare will apply the following payment policy:

• The highest-valued service, whether the E/M visit or procedure, retains 100% of its applicable Medicare fee schedule amount.

• The other affected service or services receive a 20% reduction to their applicable Medicare fee schedule amounts.

The policy applies when these services are furnished by the same physician or another physician in the same group practice.

Procedures with 10- or 90-day global periods are not included in this additional payment reduction.

Not every claim involving Modifier 25 will be affected.

Why This Matters to Podiatrists

Consider how often podiatrists evaluate patients for multiple foot conditions and perform medically necessary procedures during the same visit.

Modifier 25 allows a significant, separately identifiable E/M service to be reported alongside a procedure when the documentation supports both services.

Under the new policy, reimbursement can be reduced even when both services are medically necessary, properly documented, and correctly billed.

For practices performing these services frequently, the reduction could add up to a significant loss of revenue over time.

APMA Continues to Fight the Cuts

The American Podiatric Medical Association (APMA) strongly opposes the finalized reduction.

APMA has worked alongside other physician organizations through the Same Day Care Coalition, advocating for fair reimbursement for medically necessary same-day services.

The association warns that these cuts could place additional financial pressure on independent podiatry practices and potentially affect patients' access to timely care.

APMA is now urging Congress to establish a one-year moratorium on the payment reduction.

Podiatrists can learn more and participate through APMA's Modifier 25 Advocacy Action Page.

What Should Podiatry Practices Do Now?

With implementation scheduled for January 1, 2027, practices should begin evaluating the potential financial impact.

1. Review Modifier 25 utilization. Identify how frequently E/M visits are billed with procedures on the same date.

2. Identify affected procedures. Review commonly performed procedures with 0-day global periods.

3. Evaluate revenue exposure. Examine historical claims to estimate the potential reduction in reimbursement.

4. Verify documentation. Continue ensuring that every E/M service billed with Modifier 25 meets Medicare's requirements for separate reporting.

5. Monitor further developments. Follow CMS implementation guidance and APMA's ongoing legislative efforts.

The new payment policy does not eliminate Modifier 25 or change the requirement to accurately document and report medically necessary services.

The Bottom Line

Podiatry practices are already facing rising operating expenses, payer restrictions, documentation requirements, and reimbursement challenges.

This additional Medicare payment reduction creates another potential financial burden, especially for smaller independent practices.

At Vital Profits LLC, we believe that understanding reimbursement changes is just as important as submitting clean claims.

Accurate coding, appropriate documentation, and careful monitoring of reimbursement help protect practice revenue.

As a medical billing company specializing in podiatry, we understand the importance of keeping practices informed about changes that affect their bottom line.

We'll continue monitoring this policy and its impact on podiatry reimbursement.